Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LENZLENZ
6 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in LENZ THERAPEUTICS INC

CITADEL ADVISORS LLC holds 363,229 shares of LENZ (LENZ THERAPEUTICS INC), worth $2.1M as of 2026-Q2. This is a new position. LENZ represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$2.1M

Current Shares

363,229

Total Value Change

+$1.8M

Total Shares Change

+353,635

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
363,229
-
$2.1M0.0%$5.68
36
2026-Q1
Exited
0
-100.0%
$00.0%$13.15
0
2025-Q4
Decreased
80,574
-79.8%
$1.3M0.0%$16.12
0
2025-Q3
Increased
399,430
+4319.9%
$18.6M0.0%$44.89
46
2025-Q2
Decreased
9,037
-5.8%
$264,8740.0%$30.18
0
2025-Q1
New
9,594
-
$246,6620.0%$25.64
35

Other major holders of LENZ: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used